Decoding the RNA Operating System of the Cell with the Most Up-to-date miRNA Profiling Service

febit’s new microRNA profiling services can make researchers stay ahead in microRNA research

Heidelberg, (PresseBox) - febit biotech gmbh, a leading supplier of flexible microarray technology today announced the launch of its new miRNA profiling service. With day-to-day synthesis capability and broad flexibility of content, febit’s Geniom Biochips reflect the most up-to-date version of miRBase, the miRNA database at the Sanger Institute. In addition the biochip content is completely customizable to include capture probes for researchers own miRNA targets.

The customer can choose the degree of autonomy he needs and use three types of services:
1. Preset Geniom miRNA Biochip which is based on the latest miRBase Version 10.0, 2. the same biochip plus some sequences specified by the customer, or 3. a biochip which contains completely customized oligonucleotides for microarray analysis. miRNA profiling can be put out as a service which is offered by febit, or can be analyzed independently by ordering Geniom Ready-to-Go Biochips or even use the possibility to buy the Geniom Platform to produce up-to-date biochips in the researcher’s lab.

Ph.D. Adam Grundhoff from the Heinrich-Pette-Institute for Experimental Virology and Immunology at the University of Hamburg (Germany) stated: “For our evaluation studies we used preset Geniom Biochips based on the miRBase Version 10.0 content with additional viral sequences which are relevant for our research. The chips were analyzed with our samples by febit and we are very excited about the short handling time and the high quality results.”

Detailed information about these services are available at www.mirna-profiling.com.

Hummingbird Diagnostics GmbH

Developing innovative and creative technologies for genomic research is the corporate mission of the febit group, a German-American biotech company. Geniom is a technological and service platform successfully used in basic and applied research of renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes providing superior time and cost efficiency combined with an unsurpassed spectrum of applications (Geno-, SNP- and Pathogentyping, Enzyme-on-Chip, miRNA-Profiling and many more). With the unique Geniom Technology febit now enters the high-potential market of synthetic biology with a novel method for production of synthetic genes. Using both, highly integrated automation and extensive customizability, febit meets essential needs of current biomedical research.

www.febit.com

Diese Pressemitteilungen könnten Sie auch interessieren

Weitere Informationen zum Thema "Biotechnik":

Künstliche Intelligenz optimiert das Mobilfunknetz

Das Mo­bil­funk­netz, ein kom­ple­xes Kon­strukt aus Mo­bil­funk­stand­or­ten und Net­z­e­le­men­ten, sorgt da­für, dass Men­schen je­der­zeit und übe­rall mit­ein­an­der te­le­fo­nie­ren und ih­re di­gi­ta­len An­wen­dun­gen nut­zen kön­nen. Die In­stand­hal­tung, Über­prü­fung und Opti­mie­rung ei­ner solch viel­schich­ti­gen Struk­tur er­for­dert je­de Men­ge men­sch­li­ches und tech­ni­sches Know-how. Um kom­ple­xe Zu­sam­men­hän­ge im Mo­bil­funk­netz noch bes­ser zu ver­ste­hen, setzt Te­le­fó­ni­ca Deut­sch­land seit ei­ni­ger Zeit Al­go­rith­men und Künst­li­che In­tel­li­genz (KI) ein.

Weiterlesen

News abonnieren

Mit dem Aboservice der PresseBox, erhalten Sie tagesaktuell und zu einer gewünschten Zeit, relevante Presseinformationen aus Themengebieten, die für Sie interessant sind. Für die Zusendung der gewünschten Pressemeldungen, geben Sie bitte Ihre E-Mail-Adresse ein.

Es ist ein Fehler aufgetreten!

Vielen Dank! Sie erhalten in Kürze eine Bestätigungsemail.


Ich möchte die kostenlose Pressemail abonnieren und habe die Bedingungen hierzu gelesen und akzeptiert.